Clinical Trials Logo

Clinical Trial Summary

This Study is A Double-blind, Randomized, Placebo-controlled, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04294251
Study type Interventional
Source Daewoong Pharmaceutical Co. LTD.
Contact
Status Completed
Phase Phase 3
Start date March 4, 2020
Completion date August 10, 2021

See also
  Status Clinical Trial Phase
Completed NCT04443244 - Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy Phase 2
Recruiting NCT05964257 - To Evaluate the Efficacy and Safety of LIZTOX in Subjects With Benign Masseteric Hypertrophy Phase 3
Not yet recruiting NCT03369990 - DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy Phase 2